Testosterone alters iron metabolism and stimulates red blood cell production independently of dihydrotestosterone.

Testosterone (T) stimulates erythropoiesis and regulates iron homeostasis. However, it remains unknown whether the (type II) 5α-reduction of T to dihydrotestosterone (DHT) mediates these androgenic effects, as it does in some other tissues. Our purpose was to determine whether inhibition of type II 5α-reductase (via finasteride) alters red blood cell (RBC) production and serum markers of iron homeostasis subsequent to testosterone-enanthate (TE) administration in older hypogonadal men. Sixty men aged ≥60 yr with serum T <300 ng/dl or bioavailable T <70 ng/dl received treatment with TE (125 mg/wk) vs. vehicle paired with finasteride (5 mg/day) vs. placebo using a 2 × 2 factorial design. Over the course of 12 mo, TE increased RBC count 9%, hematocrit 4%, and hemoglobin 8% while suppressing serum hepcidin 57% (P < 0.001 for all measurements). Most of the aforementioned changes occurred in the first 3 mo of treatment, and finasteride coadministration did not significantly alter any of these effects. TE also reduced serum ferritin 32% (P = 0.002) within 3 mo of treatment initiation without altering iron, transferrin, or transferrin saturation. We conclude that TE stimulates erythropoiesis and alters iron homeostasis independently of the type II 5α-reductase enzyme. These results demonstrate that elevated DHT is not required for androgen-mediated erythropoiesis or for alterations in iron homeostasis that would appear to support iron incorporation into RBCs.

[1]  T. Travison,et al.  Testosterone induces erythrocytosis via increased erythropoietin and suppressed hepcidin: evidence for a new erythropoietin/hemoglobin set point. , 2014, The journals of gerontology. Series A, Biological sciences and medical sciences.

[2]  U. Nseyo,et al.  Musculoskeletal and prostate effects of combined testosterone and finasteride administration in older hypogonadal men: a randomized, controlled trial. , 2014, American journal of physiology. Endocrinology and metabolism.

[3]  T. Ganz,et al.  Testosterone perturbs systemic iron balance through activation of epidermal growth factor receptor signaling in the liver and repression of hepcidin , 2014, Hepatology.

[4]  Herbert Y. Lin,et al.  The liver: conductor of systemic iron balance. , 2014, Blood.

[5]  G. Grunwald,et al.  Association of testosterone therapy with mortality, myocardial infarction, and stroke in men with low testosterone levels. , 2013, JAMA.

[6]  C. Enns,et al.  Iron regulation by hepcidin. , 2013, The Journal of clinical investigation.

[7]  T. Travison,et al.  Testosterone administration inhibits hepcidin transcription and is associated with increased iron incorporation into red blood cells , 2013, Aging cell.

[8]  L. Ferrucci,et al.  Is the haematopoietic effect of testosterone mediated by erythropoietin? The results of a clinical trial in older men , 2013, Andrology.

[9]  Lei Wang,et al.  Estrogen regulates iron homeostasis through governing hepatic hepcidin expression via an estrogen response element. , 2012, Gene.

[10]  M. Tillman,et al.  17β-Hydroxyestra-4,9,11-trien-3-one (Trenbolone) preserves bone mineral density in skeletally mature orchiectomized rats without prostate enlargement. , 2012, Bone.

[11]  T. Tamaki,et al.  Estrogen Regulates Hepcidin Expression via GPR30-BMP6-Dependent Signaling in Hepatocytes , 2012, PloS one.

[12]  S. Borst,et al.  Intracrine and myotrophic roles of 5α-reductase and androgens: a review. , 2012, Medicine and science in sports and exercise.

[13]  T. Travison,et al.  Effect of testosterone supplementation with and without a dual 5α-reductase inhibitor on fat-free mass in men with suppressed testosterone production: a randomized controlled trial. , 2012, JAMA.

[14]  S. Borst,et al.  17β-Hydroxyestra-4,9,11-trien-3-one (trenbolone) exhibits tissue selective anabolic activity: effects on muscle, bone, adiposity, hemoglobin, and prostate. , 2011, American journal of physiology. Endocrinology and metabolism.

[15]  T. Travison,et al.  Testosterone suppresses hepcidin in men: a potential mechanism for testosterone-induced erythrocytosis. , 2010, The Journal of clinical endocrinology and metabolism.

[16]  V. Montori,et al.  Testosterone therapy in men with androgen deficiency syndromes: an Endocrine Society clinical practice guideline. , 2010, The Journal of clinical endocrinology and metabolism.

[17]  Amy T. Wang,et al.  Clinical review 1: Adverse effects of testosterone therapy in adult men: a systematic review and meta-analysis. , 2010, The Journal of clinical endocrinology and metabolism.

[18]  V. Langlois,et al.  Evolution of steroid-5alpha-reductases and comparison of their function with 5beta-reductase. , 2010, General and comparative endocrinology.

[19]  M. Maggio,et al.  Androgens and erythropoiesis: Past and present , 2009, Journal of endocrinological investigation.

[20]  L. Maffei,et al.  Testosterone action on erythropoiesis does not require its aromatization to estrogen: Insights from the testosterone and estrogen treatment of two aromatase-deficient men , 2009, The Journal of Steroid Biochemistry and Molecular Biology.

[21]  G. Carruba,et al.  Androgen metabolism and biotransformation in nontumoral and malignant human liver tissues and cells , 2009, The Journal of Steroid Biochemistry and Molecular Biology.

[22]  S. Bhasin,et al.  Effects of graded doses of testosterone on erythropoiesis in healthy young and older men. , 2008, The Journal of clinical endocrinology and metabolism.

[23]  C. Gregory,et al.  Anabolic effects of testosterone are preserved during inhibition of 5alpha-reductase. , 2007, American journal of physiology. Endocrinology and metabolism.

[24]  S. Bandinelli,et al.  Low testosterone levels and the risk of anemia in older men and women. , 2006, Archives of internal medicine.

[25]  Martin L. Lee,et al.  Adverse events associated with testosterone replacement in middle-aged and older men: a meta-analysis of randomized, placebo-controlled trials. , 2005, The journals of gerontology. Series A, Biological sciences and medical sciences.

[26]  A. Matsumoto,et al.  Exogenous testosterone (T) alone or with finasteride increases physical performance, grip strength, and lean body mass in older men with low serum T. , 2005, The Journal of clinical endocrinology and metabolism.

[27]  L. Dunkel,et al.  Pubertal upregulation of erythropoiesis in boys is determined primarily by androgen. , 2005, The Journal of pediatrics.

[28]  N. Watts,et al.  Exogenous testosterone or testosterone with finasteride increases bone mineral density in older men with low serum testosterone. , 2004, The Journal of clinical endocrinology and metabolism.

[29]  T. Penning,et al.  Steroid 5α-reductases and 3α-hydroxysteroid dehydrogenases: key enzymes in androgen metabolism , 2001 .

[30]  A. Vermeulen,et al.  A critical evaluation of simple methods for the estimation of free testosterone in serum. , 1999, The Journal of clinical endocrinology and metabolism.

[31]  N. Shahidi Androgens and erythropoiesis. , 1973, The New England journal of medicine.

[32]  C. Gurney,et al.  THE ERYTHROPOIETIC‐STIMULATING EFFECTS OF ANDROGENS , 1968, Annals of the New York Academy of Sciences.

[33]  W. Vaughn,et al.  Erythropoietin excretion in man following androgens. , 1967, The Journal of laboratory and clinical medicine.

[34]  J. Schooley,et al.  Inhibition of Erythropoietic Stimulation by Testosterone in Polycythemic Mice Receiving Anti-Erythropoietin.∗ , 1966, Proceedings of the Society for Experimental Biology and Medicine. Society for Experimental Biology and Medicine.

[35]  V. Montori,et al.  CLINICAL PRACTICE GUIDELINE Testosterone Therapy in Adult Men with Androgen Deficiency Syndromes: An Endocrine Society Clinical Practice Guideline , 2010 .

[36]  Jun Hak Lee,et al.  Inhibition of 5alpha-reductase blocks prostate effects of testosterone without blocking anabolic effects. , 2005, American journal of physiology. Endocrinology and metabolism.

[37]  Harm Kuipers,et al.  Effects of Androgenic-Anabolic Steroids in Athletes , 2004, Sports medicine.

[38]  Matthias W. Hentze,et al.  Hepcidin Regulates Cellular Iron Efflux by Binding to Ferroportin and Inducing Its Internalization , 2004 .

[39]  T. Penning,et al.  Steroid 5alpha-reductases and 3alpha-hydroxysteroid dehydrogenases: key enzymes in androgen metabolism. , 2001, Best practice & research. Clinical endocrinology & metabolism.